| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10917828 | Radiotherapy and Oncology | 2016 | 8 Pages |
Abstract
In summary, HPV-positive OSCC are less likely to have mutant p53 than HPV-negative OSCC. Our study did not show any evidence that p53 mutation could modify the effect of HPV status on outcomes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Angela Hong, Xiaoying Zhang, Deanna Jones, Anne-Sophie Veillard, Mei Zhang, Andrew Martin, J. Guy Lyons, C. Soon Lee, Barbara Rose,